MedTech recognizes Biologica Technologies as top startup

Written by Alan Condon | October 15, 2019 | Print  |

MedTech Outlook Magazine recognized Biologica Technologies as one of the Top 10 MedTech Startups in 2019.

Four things to know:

1. The annual MedTech list honors companies that tackle surgical challenges in orthopedics.

2. Biologica's main product, ProteiOS growth factor, is a soluble protein compound derived from the endosteum of allograft bone.

3. ProteiOS consists of a collection of growth factors, oxygenating peptides, collagen deposition peptides and cellular attachment peptides.

4. The product was initially launched for the orthopedic and neurosurgery markets.

More articles on biologics:
Dr. Adrian Park: Work-related injuries affecting orthopedic, spine surgeons & other specialists
Penn Medicine researchers seek to improve spinal discs' early response to injury
Emory, Duke & more: 4 facilities participate in $13M clinical trial for knee stem cell treatment



© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months